Jeonjinbio Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Jeonjinbio Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩313.21 Million ≈ $212.26K USD) by net assets (₩17.72 Billion ≈ $12.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jeonjinbio Co. Ltd (2015–2024)

Cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024. This chart illustrates how Jeonjinbio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 110020 share price today for real-time trading data and today's change.

Jeonjinbio Co. Ltd Cash Flow Conversion Ratio Explained

Jeonjinbio Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jeonjinbio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their cash flow conversion efficiency. Also see Jeonjinbio Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
AroCell AB ST:AROC	-0.010x
Talius Group Ltd. AU:TAL	-0.158x
Welcron Hantec Co.Ltd KQ:076080	-0.066x
Chibougamau Independent Mines Inc V:CBG	0.012x
Prizma Pres Matbaacilik Yayincilik Sanayi ve Ticaret AS IS:PRZMA	0.007x
Mynd.ai, Inc. NYSE MKT:MYND	-0.360x
Future Retail Limited NSE:FRETAIL	1.043x
Sampann Utpadan India Limited NSE:SAMPANN	-0.194x

Annual Cash Flow Conversion Efficiency for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024. Review cash generation quality of Jeonjinbio Co. Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩17.66 Billion ≈ $11.97 Million	₩3.01 Billion ≈ $2.04 Million	0.170x	+452.06%
2023-12-31	₩6.22 Billion ≈ $4.21 Million	₩-300.60 Million ≈ $-203.71K	-0.048x	+87.61%
2022-12-31	₩9.51 Billion ≈ $6.44 Million	₩-3.71 Billion ≈ $-2.51 Million	-0.390x	-76.65%
2021-12-31	₩10.80 Billion ≈ $7.32 Million	₩-2.38 Billion ≈ $-1.62 Million	-0.221x	-7.88%
2020-12-31	₩11.28 Billion ≈ $7.65 Million	₩-2.31 Billion ≈ $-1.57 Million	-0.205x	+54.32%
2019-12-31	₩2.90 Billion ≈ $1.96 Million	₩-1.30 Billion ≈ $-880.34K	-0.448x	+18.90%
2018-12-31	₩3.91 Billion ≈ $2.65 Million	₩-2.16 Billion ≈ $-1.46 Million	-0.553x	+69.24%
2017-12-31	₩229.96 Million ≈ $155.84K	₩-413.19 Million ≈ $-280.01K	-1.797x	-2154.30%
2016-12-31	₩2.28 Billion ≈ $1.55 Million	₩-181.90 Million ≈ $-123.27K	-0.080x	+94.83%
2015-12-31	₩1.27 Billion ≈ $858.87K	₩-1.95 Billion ≈ $-1.32 Million	-1.541x	--

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals

Market Cap

$13.38 Million

₩19.75 Billion KRW

Market Cap Rank

#26165 Global

#1963 in Korea

Share Price

₩2180.00

Change (1 day)

+8.46%

52-Week Range

₩1641.00 - ₩3025.00

All Time High

₩16700.00